The Nova Scotia Securities Commission has settled a case with Dr. James A. Smith today, May 13. Smith admitted to not filing insider trading reports.
Dr. Smith was a director of Medmira Inc., a reporting issuer in Nova Scotia, British Columbia, Alberta and Ontario, from March 13, 2000 to Jan. 27, 2011, inclusive. A reporting issuer is a company that sells shares to the public and has received a receipt for its prospectus from the Nova Scotia Securities Commission.
He was also chair of the board of directors. This made him an insider as defined by the Securities Act, requiring him to report any trading in Medmira Inc. shares.
During his time as a director, Dr. Smith converted 50,000 options into common shares of Medmira Inc. He then transferred them to his tax-free savings account without filing the required insider reports, which Dr. Smith acknowledged contravened section 113 of the Nova Scotia Securities Act and Part 3 of National Instrument 55-104.
Under the order and settlement agreement, Dr. Smith will pay an administrative penalty of $2,500 to the commission. He will also pay $500 in costs connected with the investigation and proceedings.
The Nova Scotia Securities Commission is the provincial government agency responsible for regulating trading in securities in the province. To view the order and settlement agreement, visit the website at www.gov.ns.ca/nssc/compliancenforce/enforproceedings.asp
FOR BROADCAST USE:
The Nova Scotia Securities Commission has settled a case
with Dr. James A. Smith, who admitted to not filing insider
trading reports while acting as a director of Medmira Inc.
Dr. Smith will pay an administrative penalty of 25-hundred
dollars to the commission and five-hundred dollars in costs
connected with the investigation and proceedings.
The order and settlement agreement is available on the
Media Contact: Scott Peacock
Nova Scotia Securities Commission